Trial Profile
Diagnostic assessment of 18F-fluciclovine (FACBC) - PET/MRI in the evaluation of suspected cerebral gliomas
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 24 May 2016
Price :
$35
*
At a glance
- Drugs Fluciclovine 18F (Primary)
- Indications Glioma
- Focus Diagnostic use
- 24 May 2016 New trial record